Haloperidol increases smoking in patients with schizophrenia (original) (raw)

Abstract

Ten patients with schizophrenia participated in 120-min free-smoking sessions when actively psychotic and free of antipsychotic medications, and again after the initiation of haloperidol treatment. During these free-smoking sessions they had access to cigarettes ad libitum. Their expired air carbon monoxide (CO) and plasma nicotine and cotinine levels were measured at the end of the 120-min free-smoking sessions. These patients smoked more after starting haloperidol treatment, relative to their baseline rate of smoking when free of antipsychotic medications, as evidenced by significantly higher expired CO and plasma nicotine levels.

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

• Acri JB, Morse DE, Popke EJ, Grunberg NE (1994) Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex. Psychopharmacology 114:369–374
  Google Scholar
• Adler LE, Hoffer LD, Wiser A, Freedman R (1993) Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856–1861
  Google Scholar
• Fibiger HC, Phillips AG (1986) Reward, motivation, cognition: psychobiology of mesotelencephalic dopamine systems. In: Bloom FE (ed) Handbook of physiology, section I: the central nervous system. William & Wilkins, Baltimore, pp 647–675
  Google Scholar
• Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986) Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993–997
  Google Scholar
• Le Houezec J, Benowitz NL (1991) Basic and clinical psychopharmacology of nicotine. Clin Chest Med 12:681–699
  Google Scholar
• McEvoy JP, Hogarty GE, Steingard S (1991) Optimal dose of neuroleptic in acute schizophrenia. Arch Gen Psychiatry 48:739–745
  Google Scholar
• McEvoy JP, Freudenreich O, McGee M, VanderZwaag C, Levin ED, Rose JE (1995) Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry (in press)
• Svensson TH, Grenhoff J, Engberg G (1990) Effect of nicotine on dynamic function of brain catecholamine neurons. In: The biology of nicotine dependence (Ciba Foundation Symposium 152). Wiley, Chichester, pp 169–185
  Google Scholar

Download references

Author information

Authors and Affiliations

1. Department of Psychiatry, Duke University, Durham, North Carolina, USA
   J. P. McEvoy, O. Freudenreich, E. D. Levin & J. E. Rose

Authors

1. J. P. McEvoy
2. O. Freudenreich
3. E. D. Levin
4. J. E. Rose

Additional information

This work was supported by grant no. DA-08434 from the National Institute of Drug Abuse (Dr. McEvoy)

Rights and permissions

About this article

Cite this article

McEvoy, J.P., Freudenreich, O., Levin, E.D. et al. Haloperidol increases smoking in patients with schizophrenia.Psychopharmacology 119, 124–126 (1995). https://doi.org/10.1007/BF02246063

Download citation

• Received: 28 November 1994
• Revised: 26 January 1995
• Issue date: May 1995
• DOI: https://doi.org/10.1007/BF02246063

Key words